FTXH
Closed
First Trust Nasdaq Pharmaceuticals Etf
26.08
+0.45 (+1.76%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 25.6285
Day's Range: 25.765 - 26.13
Send
sign up or login to leave a comment!
When Written:
26.0711
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that tracks the performance of companies in the pharmaceutical industry. The ETF is based on the Nasdaq US Smart Pharmaceuticals Index, which includes companies that are primarily engaged in the research, development, manufacture, and distribution of pharmaceuticals and biotechnology products.
FTXH was launched on September 12, 2016, and has an expense ratio of 0.60%. The ETF has a total of 32 holdings, with the top three being Amgen Inc., Gilead Sciences Inc., and Vertex Pharmaceuticals Inc. The ETF is weighted towards large-cap companies, with 68% of its holdings falling in that category.
Investors can use FTXH to gain exposure to the pharmaceutical industry, which is expected to continue growing as demand for healthcare services increases. However, investors should be aware that the industry is subject to regulatory risks, such as changes to drug pricing policies, and the ETF's performance may be affected by these risks.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
FTXH was launched on September 12, 2016, and has an expense ratio of 0.60%. The ETF has a total of 32 holdings, with the top three being Amgen Inc., Gilead Sciences Inc., and Vertex Pharmaceuticals Inc. The ETF is weighted towards large-cap companies, with 68% of its holdings falling in that category.
Investors can use FTXH to gain exposure to the pharmaceutical industry, which is expected to continue growing as demand for healthcare services increases. However, investors should be aware that the industry is subject to regulatory risks, such as changes to drug pricing policies, and the ETF's performance may be affected by these risks.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!